Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Mark W Clemens, L Jeffrey Medeiros, Charles E Butler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances
|
May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Nature Medicine
|
November 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Nature Medicine
|
June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2015
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma
Mark W Clemens, L Jeffrey Medeiros, Charles E Butler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 14, 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M Horwitz, Stephen M Ansell, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 8, 2020
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020
Neha Mehta-Shah, Steven M Horwitz, Stephen Ansell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Cancer Research Communications
|
November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma
Felicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances
|
May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2025
Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma
Franck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Nature Medicine
|
November 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Nature Medicine
|
June 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
Steven M Horwitz, Ajit J Nirmal, Jahan Rahman, et al.
Page
of 9